Evaluating the efficiency of surgical treatment of ACTH-dependent Cushing’s syndrome in the early and late postoperative period

Authors

  • G.J. Narimova Republican Specialized Scientific and Practical Medical Centre of Endocrinology of the Ministry of Health of the Republic of Uzbekistan, Tashkent, Republic of Uzbekistan

DOI:

https://doi.org/10.22141/2224-0721.13.6.2017.112888

Keywords:

ACTH-dependent Cushing’s syndrome, surgical treatment

Abstract

Background. Adrenocorticotropic hormone-dependent Cushing’s syndrome (ACTH-dependent CS) is a form of endogenous CS caused by abnormal production of ACTH, in 80 % of cases — due to ACTH oversecretion by a pituitary adenoma (Cushing’s disease), and in 20 % of cases — as a result of ectopic ACTH secretion by an extrapituitary tumor or, very rarely, due to a tumor secreting both ACTH and corticotropin-releasing hormone. The purpose of our study was to evaluate the efficiency of the treatment for ACTH-dependent CS in the postoperative period. Materials and methods. Under supervision, there were 234 patients, out of them 160 women and 74 men aged 26.38 ± 3.40 years. The set of researches included clinical, biochemical, hormonal studies and also magnetic resonance imaging. Results. Transnasal transsphenoidal adenomectomies were performed initially for 200 patients, out of them for the second time — in 34 persons. The significance of differences was certain between such parameters, as a number of patients in the period of remission and number of relapses after transnasal transsphenoidal adenomectomy, level of free plasma cortisol and glycemia in the period of remission. After analyzing the data on the remissions and relapses, the correlation between free plasma cortisol level in the early postoperative period after transnasal transsphenoidal adenomectomy and the incidence of relapses was selectively studied in patients. Conclusions. The most significant, informing prognostic marker of tumor relapse is the level of plasma cortisol in the early postoperative period.

Downloads

Download data is not yet available.

References

Castinetti F, Martinie M, Morange I, et al. A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease. J Clin Endocrinol Metab. 2009 Jun;94(6):1897-903. doi: 10.1210/jc.2008-2234.

Czepielewski MA, Rollin GA, Casagrande A, Ferreira NP. Criteria of cure and remission in Cushing's disease: an update. Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1362-72. PMID: 18209875.

Fleseriu M. Medical management of persistent and recurrent Cushing disease. Neurosurg Clin N Am. 2012 Oct;23(4):653-68. doi: 10.1016/j.nec.2012.06.012.

Hassan-Smith ZK, Sherlock M, Reulen RC, et al. Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab. 2012 Apr;97(4):1194-201. doi: 10.1210/jc.2011-2957.

Findling JW, Raff H. Diagnosis of endocrine disease: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome). Eur J Endocrinol. 2017 May;176(5):R205-R216. doi: 10.1530/EJE-16-0946.

Kuan EC, Yoo F, Kim W. et al. Anatomic Variations in Pituitary Endocrinopathies: Implications for the Surgical Corridor. J Neurol Surg B Skull Base. 2017 Apr;78(2):105-11. doi: 10.1055/s-0036-1585588.

Koutourousiou M, Winstead WI. Endoscopic Endonasal Surgery for Remission of Cushing Disease Caused by Ectopic Intracavernous Macroadenoma: Case Report and Literature Review. World Neurosurg. 2017 Feb;98:870.e5-870.e10. doi: 10.1016/j.wneu.2016.12.021.

Lambert JK, Goldberg L, Fayngold S, Kostadinov J, Post KD, Geer EB. Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients. J Clin Endocrinol Metab. 2013 Mar;98(3):1022-30. doi: 10.1210/jc.2012-2893.

Lonser RR, Wind JJ, Nieman LK, Weil RJ, DeVroom HL, Oldfield EH. Outcome of surgical treatment of 200 children with Cushing's disease. J Clin Endocrinol Metab. 2013 Mar;98(3):892-901. doi: 10.1210/jc.2012-3604.

Lindsay JR, Oldfield EH, Stratakis CA, Nieman LK. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery. J Clin Endocrinol Metab. 2011 Jul;96(7):2057-64. doi: 10.1210/jc.2011-0456.

Melo-Leite AF, Elias PC, Teixeira SR, et al. Adrenocortical neoplasms in adulthood and childhood: distinct presentation. Review of the clinical, pathological and imaging characteristics. J Pediatr Endocrinol Metab. 2017 Mar 1;30(3):253-76. doi: 10.1515/jpem-2016-0080.

Prete A, Corsello SM, Salvatori R. Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab. 2017 Mar;8(3):33-48. doi: 10.1177/2042018816687240.

Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER Jr. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease. Neurosurgery. 2008 Aug;63(2):266-70; discussion 270-1. doi: 10.1227/01.NEU.0000313117.35824.9F.

Romanholi DJ, Machado MC, Pereira CC, et al. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease. Clin Endocrinol (Oxf). 2008 Jul;69(1):117-22. doi: 10.1111/j.1365-2265.2007.03168.x.

Santos A, Crespo I, Aulinas A, Resmini E, Valassi E, Webb SM. Quality of life in Cushing's syndrome. Pituitary. 2015 Apr;18(2):195-200. doi: 10.1007/s11102-015-0640-y.

Valassi E, Biller BM, Swearingen B, et al. Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab. 2010 Feb;95(2):601-10. doi: 10.1210/jc.2009-1672.

Published

2021-09-02

How to Cite

Narimova, G. (2021). Evaluating the efficiency of surgical treatment of ACTH-dependent Cushing’s syndrome in the early and late postoperative period. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), 13(6), 440–444. https://doi.org/10.22141/2224-0721.13.6.2017.112888

Issue

Section

Endocrine Surgery